Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-28T14:15:34.222Z Has data issue: false hasContentIssue false
  • English
  • Français

Pimozide treatment for body dysmorphic disorder

Published online by Cambridge University Press:  13 June 2014

Henry O'Connell  and
Patrick G Doyle
Henry O'Connell
Affiliation:
Limerick Mental Health Services
Patrick G Doyle
Affiliation:
Limerick Mental Health Services, Tevere Day Hospital, Shelbourne Road, Limerick, Ireland
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Irish Journal of Psychological Medicine , Volume 23 , Issue 3 , September 2006 , pp. 123 - 124
Copyright
Copyright © Cambridge University Press 2006

References

1.McWilliams, S, Whitty, M, Lydon, D, Clarke, M. Body dysmorphic disorder treated with venlafaxine, olanzapine and cognitive behavioural therapy. Ir J Psych Med 2005; 22(4):143–146.CrossRefGoogle Scholar
2.Philips, KA. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. Am J Psychiatry 2005:162(2):377–9.CrossRefGoogle Scholar